Alyssa Irene Fredbo, PA-C | |
50 N Medical Dr, Salt Lake City, UT 84132-0001 | |
(651) 323-8334 | |
Not Available |
Full Name | Alyssa Irene Fredbo |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 50 N Medical Dr, Salt Lake City, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376226936 | NPI | - | NPPES |
2018031454 | Other | UT | EMT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 13455633-1206 (Utah) | Secondary |
363A00000X | Physician Assistant | 13455633-1206 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alyssa Irene Fredbo, PA-C 2100 Park Ave Unit 682858, Park City, UT 84068-4615 Ph: () - | Alyssa Irene Fredbo, PA-C 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (651) 323-8334 |
News Archive
In a disease like ALS - one that's always fatal and that has a long history of research-resistant biology - finding a proof of principle in animal models is significant.
Current screening strategies for Down syndrome, caused by fetal trisomy 21 (T21), and Edwards syndrome, caused by fetal trisomy 18 (T18), have false positive rates of 2 to 3%, and false negative rates of 5% or higher. Positive screening results must be confirmed by amniocentesis or chorionic villus sampling, which carry a fetal loss rate of approximately 1 in 300 procedures. Now an international, multicenter cohort study finds that a genetic test to screen for trisomy 21 or 18 from a maternal blood sample is almost 100% accurate.
Federal health officials gave two firms - the Certification Commission for Health Information Technology in Chicago, Ill., and the Drummond Group in Austin, Texas, - the power to certify electronic medical record vendors effective immediately, The Hill reports. "As providers move toward mandatory adoption of EHR systems, HHS created an incentive program designed to encourage the transition." Hospitals and doctors can receive payments for achieving "meaningful use," a set of requirements laid out by federal officials.
PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has solidified plans to expand its retail product line with the addition of spirulla.
In the U.S., about 13 percent of women and 10 percent of men aged 60 or older have knee pain due to osteoarthritis. Osteoarthritis occurs when a joint becomes inflamed, usually because the protective cartilage and other tissues that cushion joints like the knee become damaged and worn over time.
› Verified 3 days ago